| Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer G Jiang, S Zhang, A Yazdanparast, M Li, AV Pawar, Y Liu, SM Inavolu, ... BMC genomics 17, 281-301, 2016 | 227 | 2016 |
| Exogenous gene transmission of isocitrate dehydrogenase 2 mimics ischemic preconditioning protection AL Kolb, PR Corridon, S Zhang, W Xu, FA Witzmann, JA Collett, ... Journal of the American Society of Nephrology 29 (4), 1154-1164, 2018 | 30 | 2018 |
| Translational high‐dimensional drug interaction discovery and validation using health record databases and pharmacokinetics models CW Chiang, P Zhang, X Wang, L Wang, S Zhang, X Ning, L Shen, ... Clinical Pharmacology & Therapeutics 103 (2), 287-295, 2018 | 29 | 2018 |
| Advances in the synthesis of isatins: a survey of the last decade AV Bogdanov, VF Mironov Synthesis 50 (08), 1601-1609, 2018 | 23 | 2018 |
| Comparative assessment of manual chart review and ICD claims data in evaluating immunotherapy-related adverse events A Nashed, S Zhang, CW Chiang, M Zitu, GA Otterson, CJ Presley, ... Cancer Immunology, Immunotherapy, 1-9, 2021 | 14 | 2021 |
| Translational knowledge discovery between drug interactions and pharmacogenetics HY Wu, A Shendre, S Zhang, P Zhang, L Wang, D Zeruesenay, LM Rocha, ... Clinical Pharmacology & Therapeutics 107 (4), 886-902, 2020 | 13 | 2020 |
| IODNE: An integrated optimization method for identifying the deregulated subnetwork for precision medicine in cancer S Mounika Inavolu, J Renbarger, M Radovich, V Vasudevaraja, ... CPT: pharmacometrics & systems pharmacology 6 (3), 168-176, 2017 | 13 | 2017 |
| Subpathway analysis of transcriptome profiles reveals new molecular mechanisms of acquired chemotherapy resistance in breast cancer Y Huo, S Shao, E Liu, J Li, Z Tian, X Wu, S Zhang, D Stover, H Wu, ... Cancers 14 (19), 4878, 2022 | 12 | 2022 |
| Generalizability of machine learning methods in detecting adverse drug events from clinical narratives in electronic medical records MM Zitu, S Zhang, DH Owen, C Chiang, L Li Frontiers in Pharmacology 14, 1218679, 2023 | 11 | 2023 |
| PhenoDEF: a corpus for annotating sentences with information of phenotype definitions in biomedical literature S Binkheder, HY Wu, SK Quinney, S Zhang, MM Zitu, CW Chiang, L Wang, ... Journal of biomedical semantics 13 (1), 17, 2022 | 6 | 2022 |
| Translational drug–interaction corpus S Zhang, H Wu, L Wang, G Zhang, LM Rocha, H Shatkay, L Li Database 2022, baac031, 2022 | 6 | 2022 |
| Identifying experimental evidence in biomedical abstracts relevant to drug-drug interactions G Zhang, D Roychowdhury, P Li, HY Wu, S Zhang, L Li, H Shatkay Proceedings of the 2018 ACM International Conference on Bioinformatics …, 2018 | 5 | 2018 |
| Translational drug interaction evidence gap discovery using text mining HY Wu, S Zhang, Z Desta, S Quinney, L Li Clinical Pharmacology & Therapeutics 101 (S 1), S91-S92, 2017 | 5 | 2017 |
| DrugMetab: an integrated machine learning and lexicon mapping named entity recognition method for drug metabolite HY Wu, D Lu, M Hyder, S Zhang, SK Quinney, Z Desta, L Li CPT: Pharmacometrics & Systems Pharmacology 7 (11), 709-717, 2018 | 4 | 2018 |
| Hydrodynamic delivery of mitochondrial genes in vivo protects against moderate ischemia‐reperfusion injury in the rat kidney (690.17) P Corridon, G Rhodes, S Zhang, D Bready, W Xu, F Witzmann, S Atkinson, ... The FASEB Journal 28, 690.17, 2014 | 2 | 2014 |
| Multiple sampling schemes and deep learning improve active learning performance in drug-drug interaction information retrieval analysis from the literature W Xie, K Fan, S Zhang, L Li Journal of Biomedical Semantics 14 (1), 5, 2023 | 1 | 2023 |
| An Informatics Bridge to Improve the Design and Efficiency of Phase I Clinical Trials for Anticancer Drug Combinations L Wang, L Wei, S Zhang, L Cheng, A Shendre, W Carson, JL Chen, ... Cancer research communications 2 (9), 929-936, 2022 | 1 | 2022 |
| Detection of Patient-Level Immunotherapy-Related Adverse Events (irAEs) from Clinical Narratives of Electronic Health Records: A High-Sensitivity Artificial Intelligence Model MM Zitu, ME Gatti-Mays, KC Johnson, S Zhang, A Shendre, MI Elsaid, L Li Pragmatic and Observational Research, 243-252, 2024 | | 2024 |
| Utilizing Drug Combo to improve the design of phase 1 trials for anticancer drugs. L Wang, S Zhang, L Wei, DH Owen, L Li Journal of Clinical Oncology 41 (16_suppl), 1571-1571, 2023 | | 2023 |
| Drug Combo: A unique resource for efficient phase 1 trial design with manually curated MTD and DLT L Wang, S Zhang, L Wei, Y Zhu, D Owen, L Li Cancer Research 83 (7_Supplement), 6573-6573, 2023 | | 2023 |
